SCHEMBL8287237

SCHEMBL8287237

O=C(COc1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1)N1CCOCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.43
ALDH1A1 P00352 3/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 4/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 2/20 0.40
HSD17B10 Q99714 1/20 0.40
FKBP1A P62942 2/20 0.39
EGFR P00533 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
TNK2 Q07912 1/20 0.38
TSHR P16473 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287240 0.85 HTT (0.41) PDE11AALDH1A1MAPTHPGDKDM4E
SCHEMBL8287591 0.85 LMNA (0.42) PDE11AALDH1A1LMNAMAPTHPGD
SCHEMBL8287462 0.83 PDE11A (0.44) PDE11AALDH1A1MAPTHPGDKDM4E
SCHEMBL8287452 0.80 PDE11A (0.55) PDE11AALDH1A1LMNAKDM4E
SCHEMBL8287248 0.80 MEN1 (0.43) ALDH1A1LMNAMAPTKDM4EHSD17B10
SCHEMBL8287241 0.80 RAB9A (0.40) ALDH1A1KDM4ECYP2C9
SCHEMBL8285261 0.79 GSK3B (0.38) PDE11AALDH1A1MAPTHPGDKDM4E
SCHEMBL8285340 0.79 PDE11A (0.45) PDE11AALDH1A1LMNAMAPTHPGD
SCHEMBL8285335 0.78 MAT2A (0.37) PDE11AHPGDGAA
SCHEMBL8287459 0.78 GABRP (0.38) PDE11AALDH1A1MAPTL3MBTL1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed